Biomarkers of vascular cognitive impairment
Open Access
- 14 May 2021
- journal article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 20 (3), 2677
- https://doi.org/10.15829/1728-8800-2021-2677
Abstract
There is currently no approved list of vascular cognitive impairment biomarkers. The main problem for the practitioner in identifying cognitive impairment in patients is the differential diagnosis of Alzheimer's disease, vascular cognitive impairment, and other diseases, which are much less common. Vascular cognitive impairment includes post-stroke dementia, cognitive dysfunction in cardio-and cerebrovascular diseases. Without etiology identification, it is impossible to prescribe adequate treatment. Another challenge is identifying cognitive impairment before dementia develops. This literature review is devoted to the search and critical analysis of candidates for biomarkers of vascular cognitive impairment and the establishment of markers of moderate cognitive dysfunction. The papers were searched for in the Web of Science and PubMed databases. A list of cerebrospinal fluid, plasma, serum and genetic biomarkers was made, allowing for differential diagnosis between vascular impairment and Alzheimer's disease. The markers of moderate cognitive dysfunction, which make it possible to identify cognitive impairment at the pre-dementia stage, were also identified.Keywords
This publication has 42 references indexed in Scilit:
- Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus reportBMC Neurology, 2017
- Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarkerTrends in Neurosciences, 2015
- Glial fibrillary acidic protein: The component of iintermediate filaments in the vertebrate brain astrocytesJournal of Evolutionary Biochemistry and Physiology, 2015
- COGNITIVE DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASEBulletin of Siberian Medicine, 2014
- Microglial Markers are Elevated in the Prodromal Phase of Alzheimer's Disease and Vascular DementiaJournal of Alzheimer's Disease, 2012
- Memory aging and brain maintenanceTrends in Cognitive Sciences, 2012
- Coronary heart disease is associated with non-amnestic mild cognitive impairmentNeurobiology of Aging, 2010
- Neurobiochemical Markers of Brain Damage in Cerebrospinal Fluid of Acute Ischemic Stroke PatientsClinical Chemistry, 2010
- Plasma and CSF serpins in Alzheimer disease and dementia with Lewy bodiesNeurology, 2007
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001